NEW YORK, Oct. 31, 2016 /PRNewswire/ --
Electronics for Imaging, Inc. (EFII)
Lifshitz & Miller announces investigation on behalf of EFII
investors. The investigation concerns whether EFII adequately
disclosed its earnings, projections and price targets.
If you are an EFII investor, and would like additional
information about our investigation, please complete the
Information Request Form or contact Joshua Lifshitz, Esq. by
telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Ferrellgas Partners LP (FGP)
Lifshitz & Miller announces investigation on behalf of FGP
investors. The investigation concerns FGP's reporting of poor
earnings in its 2015 annual report and that FGP may reduce the
annual distribution to shareholders by more than half.
If you are an FGP investor, and would like additional
information about our investigation, please complete the
Information Request Form or contact Joshua Lifshitz, Esq. by
telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Fusion Pharm, Inc. (FSPM)
Lifshitz & Miller announces investigation on behalf of
Fusion investors. The investigation concerns whether Fusion
inflated FSPM's revenues for purported sales of PharmPods.
If you are a FSPM investor, and would like additional
information about our investigation, please complete the
Information Request Form or contact Joshua Lifshitz, Esq. by
telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Humana Inc. (HUM)
Lifshitz & Miller announces investigation on behalf of
Humana investors. The investigation concerns whether Humana
adequately disclosed Humana's membership percentage in plans rated
four stars or higher.
If you are a Humana investor, and would like additional
information about our investigation, please complete the
Information Request Form or contact Joshua Lifshitz, Esq. by
telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
KemPharm, Inc. (KMPH)
Lifshitz & Miller announces investigation on behalf of KMPH
investors. The investigation concerns whether KMPH adequately
disclosed material information about Apadaz.
If you are a KMPH investor, and would like additional
information about our investigation, please complete the
Information Request Form or contact Joshua Lifshitz, Esq. by
telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
National Beverage Corp. (FIZZ)
Lifshitz & Miller announces investigation on behalf of FIZZ
investors. The investigation concerns a report by Glaucus
Research, which alleged that FIZZ's former CEO manipulated
earnings, refused to provide adequate due diligence for a potential
acquirer, and that insiders are compensated from a private
corporation, outside of shareholder visibility.
If you are an FIZZ investor, and would like additional
information about our investigation, please complete the
Information Request Form or contact Joshua Lifshitz, Esq. by
telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Puma Biotechnology, Inc. (PBYI)
Lifshitz & Miller announces investigation on behalf of Puma
investors. The investigation concerns whether Puma adequately
disclosed the efficacy for Puma's drug candidate Neratinib.
If you are a Puma investor, and would like additional
information about our investigation, please complete the
Information Request Form or contact Joshua Lifshitz, Esq. by
telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
TG Therapeutics, Inc. (TGTX)
Lifshitz & Miller announces investigation on behalf of TGTX
investors. The investigation concerns whether TGTX adequately
disclosed TGTX's GENUINE study.
For additional information about our investigation, please
complete the Information Request Form or contact Joshua Lifshitz,
Esq. by telephone at (516)493-9780 or e-mail at
info@jlclasslaw.com.
ATTORNEY ADVERTISING. © 2016 Lifshitz &
Miller. The law firm responsible for this advertisement is
Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel:
(516)493-9780. Prior results do not guarantee or predict a
similar outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz,
Esq.
Lifshitz & Miller
Phone: 516-493-9780
Facsimile: 516-280-7376
Email:
info@jlclasslaw.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/lifshitz--miller-law-firm-announces-investigation-of-electronics-for-imaging-inc-ferrellgas-partners-lp-fusion-pharm-inc-humana-inc-kempharm-inc-national-beverage-corp-puma-biotechnology-inc-and-tg-therapeutics--300354094.html
SOURCE Lifshitz & Miller Law Firm